Dasgupta Lab to Present at Experimental Biology 2012
Dr. Piyali Dasgupta, Assistant Professor in the Department of Pharmacology, Physiology, and Toxicology at the Joan C. Edwards School of Medicine, was selected to serve as co-chair of the special session Modeling Cancer: Biological and Therapeutic Implications at the upcoming Experimental Biology 2012 Conference. Experimental Biology is an annual conference that attracts ~14,000 scientists and more than 30 societies. In addition, Dr. Dasgupta and four members of her laboratory were selected, through a competitive process, to give the following oral presentations:
Ms. Kathleen Brown, a graduate student in the Forensics Science Graduate Program, will present "The alpha-7-nicotinic receptor antagonist induces robust apoptosis in human SCLC" as part of the Combating Cancer through Improved Diagnosis and Therapeutics session on Tuesday, April 24, 2012. She was also selected to present this research in poster format at the special session
Highlights: Graduate Student Research in Pathology as part of the American Society for Investigative Pathology Annual Meeting, to be held on Saturday, April 21, 2012.
Mr. Clayton Crabtree, a senior Biological Sciences major, will present "Capsaicin induces apoptosis in human small cell lung cancer via the TRPV pathway" as part of the Pulmonary Pathobiology session on Sunday, April 22, 2012.
Dr. Piyali Dasgupta will present "Nicotine induces the up-regulation of alpha-7-nicotinic receptors (α7-nAChRs) in human squamous cell lung cancer cells via transcriptional mechanisms" as part of the Modeling Cancer: Biological and Therapeutic Implications session on Wednesday, April 25, 2012.
Mr. Aaron Dom, a first-year student
at the Joan C. Edwards School of Medicine, will present "MG624, an α7-nicotinic receptor antagonist inhibits angiogenesis in human small cell lung cancer" at the To Grow or Not to Grow session on Saturday, April 21, 2012.
Ms. Jamie Lau, a doctoral candidate at Ball State University and laboratory technician in the Dasgupta lab, will present "Tobacco components activate the acetylcholine signaling pathway in bronchioalveolar carcinoma" at the Modeling Cancer: Biological and Therapeutic Implications session on Wednesday, April 25, 2012.
This year's meeting will be held April 21-25, 2012, in San Diego, California.
MU-ADVANCE Home Page